NCT00843908

Brief Summary

The aim of this study is to assess whether the Miniarc suburethral sling is equivalent to the TVT in the treatment of women with urodynamic stress incontinence (USI). If equivalence is proven, the advantages to women with USI will be potentially significant since the Miniarc may be carried out as an office based procedure, negating the need for an anaesthetic and hospital admission. The investigators null hypothesis is that there is no difference in subjective or objective outcome between the TVT and the Miniarc in the treatment of USI. Eligible women will be initially assessed with a full history and examination, King's Health Questionnaire and twin channel subtraction cystometry. They will be randomised (using a series of numbered opaque envelopes) to undergo either the TVT or Miniarc. Follow up will be at 6 weeks, with a subjective outcome measure and at 6 months with a repeat subjective assessment and repeat twin channel cystometry.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
70

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Feb 2008

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2008

Completed
1 year until next milestone

First Submitted

Initial submission to the registry

February 12, 2009

Completed
1 day until next milestone

First Posted

Study publicly available on registry

February 13, 2009

Completed
16 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2009

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2009

Completed
Last Updated

August 27, 2009

Status Verified

August 1, 2009

Enrollment Period

1.1 years

First QC Date

February 12, 2009

Last Update Submit

August 26, 2009

Conditions

Keywords

Stress incontinenceSurgical TreatmentsMinislings

Outcome Measures

Primary Outcomes (1)

  • The absence of stress incontinence at 6 weeks ascertained by direct questioning and from the Kings Quality of life questionnaire and the absence at 6 months by the same criteria and by urodynamics.

    6 weeks and 6 months

Secondary Outcomes (3)

  • Quality of life (as measured using the King's Health Questionnaire)

    6 weeks and 6 months

  • Intra-operative complications, e.g. bladder injury

    Time of surgery

  • Post-operative voiding dysfunction

    0-6 weeks

Study Arms (2)

TVT

ACTIVE COMPARATOR

Women in this arm will undergo the Tension Free Vaginal Tape procedure

Device: Tension Free Vaginal Tape

Miniarc

EXPERIMENTAL

Women in this group will undergo the Miniarc suburethral sling procedure

Device: Miniarc

Interventions

Tension Free Vaginal Tape inserted in the conventional manner in a theatre environment

Also known as: Advantage TVT, Boston Scientific
TVT
MiniarcDEVICE

The Miniarc suburethral sling will be inserted in the conventional manner in a theatre environment under general anaesthesia

Also known as: Miniarc, American Medical Systems
Miniarc

Eligibility Criteria

Sexfemale
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Patients must be female
  • Subjective evidence of stress predominant symptoms on symptom specific questionnaire
  • Stress incontinence on urodynamics
  • Patients who are capable of understanding and signing the written consent form for participation in the study
  • Patients must have completed their family
  • Patients must be capable of filling in the symptom diary and micturition diary

You may not qualify if:

  • Patients who are medically unfit to undergo surgical intervention.
  • Patients who have undergone previous continence surgery
  • Prolapse beyond the introitus
  • Patients with voiding dysfunction
  • Patients with recurrent urinary tract infections
  • Patients with haematuria of unknown origin or known bladder pathology
  • Patients who are not sure that their family is complete
  • Patients unwilling to use a safe method of contraception following the procedure

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Medway Maritime Hospital

Gillingham, Kent, ME7 5NY, United Kingdom

Location

Related Publications (1)

  • Carter E, Johnson EE, Still M, Al-Assaf AS, Bryant A, Aluko P, Jeffery ST, Nambiar A. Single-incision sling operations for urinary incontinence in women. Cochrane Database Syst Rev. 2023 Oct 27;10(10):CD008709. doi: 10.1002/14651858.CD008709.pub4.

MeSH Terms

Conditions

Urinary Incontinence, Stress

Interventions

Suburethral Slings

Condition Hierarchy (Ancestors)

Urinary IncontinenceUrination DisordersUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesLower Urinary Tract SymptomsUrological ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Prostheses and ImplantsEquipment and Supplies

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER

Study Record Dates

First Submitted

February 12, 2009

First Posted

February 13, 2009

Study Start

February 1, 2008

Primary Completion

March 1, 2009

Study Completion

August 1, 2009

Last Updated

August 27, 2009

Record last verified: 2009-08

Locations